OMCL Omnicell Inc

$30.25

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/7/2025

About Omnicell Inc

Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.

Website: https://www.omnicell.com

Sector
TECHNOLOGY
Industry
ELECTRONIC COMPUTERS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
926326
Address
590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW, CA, US
Valuation
Market Cap
$1.42B
P/E Ratio
112.15
PEG Ratio
2.28
Price to Book
1.14
Performance
EPS
$0.27
Dividend Yield
Profit Margin
1.13%
ROE
1.03%
Technicals
50D MA
$35.88
200D MA
$40.29
52W High
$55.74
52W Low
$25.12
Fundamentals
Shares Outstanding
47M
Target Price
$50.71
Beta
0.79

OMCL EPS Estimates vs Actual

Estimated
Actual

OMCL News & Sentiment

Oct 07, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is Omnicell ( OMCL ) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Oct 07, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Reasons to Add Omnicell Stock to Your Portfolio Right Now
OMCL's expanding SaaS portfolio, overseas growth plans, and solid balance sheet position it for sustained momentum despite rising competition.
Oct 01, 2025 • Zacks Commentary BULLISH
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Oct 01, 2025 • Zacks Commentary SOMEWHAT-BULLISH
BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience
BDX partners with Henry Ford Health to deploy BD Rowa Vmax robots, aiming to streamline 24/7 pharmacy access in Michigan.
Sep 30, 2025 • Zacks Commentary SOMEWHAT-BULLISH
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?
OPRX posts 55% revenue growth and raises outlook as AI-driven workflow integration fuels leverage and pharma adoption.
Sep 18, 2025 • Zacks Commentary BULLISH
Is Omnicell ( OMCL ) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sentiment Snapshot

Average Sentiment Score:

0.332
50 articles with scored sentiment

Overall Sentiment:

Bullish

OMCL Reported Earnings

Jul 31, 2025
Jun 30, 2025 (Pre market)
0.18 Surprise
  • Reported EPS: $0.45
  • Estimate: $0.27
  • Whisper:
  • Surprise %: 66.7%
May 06, 2025
Mar 31, 2025 (Pre market)
0.06 Surprise
  • Reported EPS: $0.26
  • Estimate: $0.20
  • Whisper:
  • Surprise %: 30.0%
Feb 06, 2025
Dec 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.60
  • Estimate: $0.58
  • Whisper:
  • Surprise %: 3.5%
Oct 30, 2024
Sep 30, 2024 (Pre market)
0.14 Surprise
  • Reported EPS: $0.56
  • Estimate: $0.42
  • Whisper:
  • Surprise %: 33.3%
Aug 01, 2024
Jun 30, 2024 (Pre market)
0.37 Surprise
  • Reported EPS: $0.51
  • Estimate: $0.14
  • Whisper:
  • Surprise %: 264.3%
May 02, 2024
Mar 31, 2024 (Pre market)
0.12 Surprise
  • Reported EPS: $0.03
  • Estimate: $-0.09
  • Whisper:
  • Surprise %: 133.3%
Feb 08, 2024
Dec 31, 2023 (Pre market)
0.18 Surprise
  • Reported EPS: $0.33
  • Estimate: $0.15
  • Whisper:
  • Surprise %: 120.0%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.15 Surprise
  • Reported EPS: $0.62
  • Estimate: $0.47
  • Whisper:
  • Surprise %: 31.9%
Aug 01, 2023
Jun 30, 2023 (Post market)
0.29 Surprise
  • Reported EPS: $0.57
  • Estimate: $0.28
  • Whisper:
  • Surprise %: 103.6%

Financials